Clinical Immunology and Allergy
Royal College of Physicians and Surgeons of Canada · 1.1 · 20 EPAs
Also available in French.
Every EPA in the published guide, shown as the form DebriefMD fills in, with its fields and answer options.
Transition to Discipline
TTD-1AP
Acquiring a baseline history and physical exam for patients with allergic and immunologic conditions
Key features and assessment plan
- This EPA focuses on the application of the skills of Internal Medicine/Pediatrics to perform specialty-specific consults. - This includes performing a focused history and physical exam, synthesizing that information and presenting the case.
Direct observation and/or case review by faculty or senior trainee Use form 1. Form collects information on: - Observation type: direct; case review - Category: allergic; immunologic - Age: infant; toddler; child; adolescent; adult; older adult - Setting: inpatient; outpatient; ER; critical care - Event observed (check all that apply): history; physical; case presentation Collect 3 observations of achievement. - At least 2 direct observations - At least 1 observation of all events (history/physical/case presentation) in a continual observation - At least 2 different assessors - At least 2 observations by faculty
Suggested observations: 3
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Observation type
- direct
- case review
Category
- allergic
- immunologic
Age
- infant
- toddler
- child
- adolescent
- adult
- older adult
Setting
- inpatient
- outpatient
- ER
- critical care
Event observed (check all that apply)
- history
- physical
- case presentation
Medical Expert
- ME 2.2 Elicit an accurate, relevant history
- ME 2.2 Perform a physical exam that informs the diagnosis
- ME 2.2 Synthesize and interpret information from the clinical assessment
- ME 2.2 Synthesize clinical findings for presentation to a supervisor CLINICAL IMMUNOLOGY AND ALLERGY (2021) (MINOR REVISIONS – OCTOBER 2023)
Communicator
- COM 1.1 Communicate using a patient-centred approach that encourages patient trust and autonomy and is characterized by empathy, respect, and compassion CLINICAL IMMUNOLOGY AND ALLERGY (2021) (MINOR REVISIONS – OCTOBER 2023)
- COM 2.1 Conduct a patient-centered interview
- COM 5.1 Maintain accurate and up-to-date problem lists and medication lists
- COM 5.1 Document the essential elements of a clinical encounter using a structured approach
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
TTD-2AP
Documenting clinical encounters in a consult letter
Key features and assessment plan
- This includes a synthesis of the clinical encounter, including pertinent clinical findings, investigations and management plan. - The role of the specialist physician and the referring physician in further care should be clearly articulated. - A consult letter is focused, complete, organized, timely, problem oriented and informative, and uses language that is clear and respectful.
Review of consult letter by faculty Use form 1. Form collects information on: - Category: allergic; immunologic - Setting: inpatient; outpatient Collect 3 observations of achievement. - At least 2 different observers
Suggested observations: 3
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Category
- allergic
- immunologic
Setting
- inpatient
- outpatient
Medical Expert
- ME 2.2 Synthesize and interpret information from the clinical assessment
Communicator
- COM 5.1 Maintain accurate and up-to date problem lists and medication lists
- COM 5.1 Organize information in appropriate sections
- COM 5.1 Document all relevant findings and investigations
- COM 5.1 Convey clinical reasoning and the rationale for decisions
- COM 5.1 Provide a clear plan for ongoing management
- COM 5.1 Adapt the written consultation to the specific clinical context
Collaborator
- COL 1.3 Provide written documentation in a timely manner
- COL 1.3 Share expertise when acting in the consultant role, using referral as an opportunity to improve quality of care CLINICAL IMMUNOLOGY AND ALLERGY (2021) (MINOR REVISIONS – OCTOBER 2023)
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
TTD-3AP
Identifying and assessing patients with medical emergencies, providing initial management, and obtaining…
Key features and assessment plan
- This EPA focuses on the recognition and initial management of unstable clinical immunology and allergy presentations. - Examples include: allergic reactions including anaphylaxis; unstable asthma; angioedema; transfusion/infusion reactions - This EPA may be observed in a simulation setting.
Direct observation by faculty or senior trainee Use form 1. Form collects information on: - Category: allergic; immunologic - Presentation (write in): - Age: infant; toddler; child; adolescent; adult; older adult - Setting: inpatient; outpatient; medical day unit; ER; ICU; simulation; other setting (write in) Collect 2 observations of achievement. - At least 2 different observers - At least 1 observation by faculty
Suggested observations: 2
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Category
- allergic
- immunologic
Medical Expert
- ME 1.4 Recognize urgent problems that may need the involvement of more experienced physicians and seek their assistance
- ME 2.2 Perform a focused history and physical exam
- ME 2.1 Address primary priorities of resuscitation (airway, breathing, circulation)
- ME 2.4 Implement initial management plans for common acute unstable presentations
Communicator
- COM 3.1 Provide explanations and updates to the patient and family
Collaborator
- COL 3.2 Provide specific information required for safe and effective handover to senior colleagues
Professional
- P 1.1 Consistently prioritize the needs of patients and others to ensure a patient’s legitimate needs are met CLINICAL IMMUNOLOGY AND ALLERGY (2021) (MINOR REVISIONS – OCTOBER 2023)
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
TTD-4AP
Performing the basic procedures of Clinical Immunology and Allergy
Key features and assessment plan
- This EPA focuses on performing epicutaneous testing, intradermal testing, and subcutaneous injections. It may also include intramuscular injections. - This EPA does not require interpretation of the findings. - The observation of this EPA is based on direct observation of the procedure.
Direct observation by faculty, other health professional adequately trained in performing the procedures of Clinical Immunology and Allergy, or senior trainee Use form 1. Form collects information on: - Case mix: epicutaneous testing; intradermal testing; intramuscular injection; subcutaneous injection - Setting: inpatient; outpatient; simulation - Age: infant/toddler; child; adolescent; adult; older adult Collect 6 observations of achievement. - At least 2 different observers - At least 2 series of epicutaneous testing - At least 1 by faculty for epicutaneous testing - At least 1 intradermal testing, may be observed in simulation setting - At least 1 subcutaneous injection
Suggested observations: 6
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Case mix
- epicutaneous testing
- intradermal testing
- intramuscular injection
- subcutaneous injection
Setting
- inpatient
- outpatient
- simulation
Age
- infant/toddler
- child
- adolescent
- adult
- older adult
Medical Expert
- ME 3.2 Demonstrate knowledge of the indications and contraindications for the procedure
- ME 3.2 Obtain informed consent
- ME 3.4 Assemble/gather the equipment
- ME 3.4 Prepare and position the patient for the procedure
- ME 3.4 Demonstrate aseptic technique: establish and respect the sterile field
- ME 3.4 Maintain universal precautions; handle sharps safely
- ME 3.4 Execute the steps of the procedure in a safe and efficient manner
- ME 3.4 Recognize and manage common complications of basic procedures CLINICAL IMMUNOLOGY AND ALLERGY (2021) (MINOR REVISIONS – OCTOBER 2023)
- ME 3.4 Seek assistance as needed when unanticipated findings or changing clinical circumstances are encountered CLINICAL IMMUNOLOGY AND ALLERGY (2021) (MINOR REVISIONS – OCTOBER 2023)
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
Foundations
F-1AP
Assessing and providing targeted treatment for patients with medical emergencies
Key features and assessment plan
- This EPA focuses on the targeted treatment of patients who are presenting with urgent or emergent conditions such as: allergic reactions including anaphylaxis, unstable asthma, angioedema, provocation challenge reactions, transfusion/infusion reactions, and other medical emergencies (such as severe combined immunodeficiency (SCID). - This EPA includes recognizing one’s limitations and seeking assistance when appropriate. - The observation of this EPA is divided into two parts: patient care, and working effectively with the interprofessional team. - This EPA may be observed in a simulation setting.
Part A: Overall patient care Direct observation and/or case review by faculty or senior trainee Use form 2. Form collects information on: - Observation type: direct; case review - Category: allergic; immunologic - Presentation (write in): - Age: infant; toddler; child; adolescent; adult; older adult - Setting: inpatient; outpatient; medical day unit; ER; ICU; simulation Collect 2 observations of achievement. - A variety of clinical presentations - At least 1 observation by faculty Part B: Working effectively with the interprofessional team Direct observation by faculty, senior trainee, or nurse, and may include input from other members of the team Use form 1. Form collects information on: - Includes feedback from: nurse; nurse practitioner; respiratory therapist; physician; other learners; other health professional Collect 2 observations of achievement. - At least 2 people providing feedback for each observation, of which at least 1 is not a physician CLINICAL IMMUNOLOGY AND ALLERGY (2021) (MINOR REVISIONS – OCTOBER 2023)
Suggested observations: 2
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Observation type
- direct
- case review
Category
- allergic
- immunologic
Medical Expert
- Part A: ME 2.1 Recognize instability and medical acuity in a clinical presentation
- Part A: ME 2.1 Establish priorities for resuscitation and/or emergency management
- Part A: ME 1.4 Recognize urgent problems that may need the involvement of more experienced colleagues and seek their assistance immediately
- Part A: ME 2.2 Focus the assessment, performing in a time-effective manner without excluding key elements
- Part A: ME 2.2 Select and interpret investigations, based on clinical priorities
- Part A: ME 2.2 Synthesize patient information to determine differential diagnosis
- Part A: ME 2.4 Develop and implement focused treatment strategies
- Part A: ME 4.1 Determine the need and timing of referral to another health care professional or setting
Communicator
- Part A: COM 1.5 Recognize when strong emotions (such as anger, fear, anxiety, or sadness) are impacting an interaction and respond appropriately
- Part A: COM 3.1 Provide information to patients and their families clearly and compassionately
Collaborator
- Part A: COL 3.2 Organize the handover of care to the most appropriate physician or health care professional
- Part B: COL 2.1 Delegate tasks and responsibilities in an appropriate and respectful manner
- Part B: COL 1.3 Apply closed loop communication in urgent or crisis situations
Leader
- Part B: L 4.2 Establish clear leadership in managing emergencies, assuming the leadership role as appropriate
Professional
- Part B: P 4.1 Maintain capacity for professional clinical performance in stressful situations CLINICAL IMMUNOLOGY AND ALLERGY (2021) (MINOR REVISIONS – OCTOBER 2023)
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
F-2AP
Assessing and initiating management of patients with common and/or uncomplicated allergic and immunologic …
Key features and assessment plan
- This EPA focuses on the initial diagnostic approach to patients with a range of common presentations. - This includes decisions about further investigations and testing, and may include identifying patients who are candidates for treatments such as medications, immunotherapy, immunoglobulin replacement and biologics. - This EPA does not include patients with complex presentations.
Direct observation and/or review of case, consult letter, patient instruction forms and/or action plan by faculty or senior trainee Use form 2. Form collects information on: - Category: allergic; immunologic - Clinical presentation (write in): - Age: infant; toddler; child; adolescent; adult; older adult - Setting: inpatient; outpatient; ER; ICU Collect 4 observations of achievement - A variety of clinical presentations - A variety of ages - At least 2 different observers - At least 2 observations by faculty observers
Suggested observations: 4
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Category
- allergic
- immunologic
Medical Expert
- ME 1.3 Apply clinical and basic sciences to manage common patient presentations in Clinical Immunology and Allergy
- ME 1.4 Perform an appropriate assessment for a patient with a common and/or uncomplicated allergic and immunologic presentations
- ME 2.2 Generate a differential diagnosis and appropriate diagnostic strategy
- ME 2.2 Select and interpret investigations, based on clinical priorities
- ME 2.4 Develop and implement initial management plans
- ME 3.1 Describe to patients common procedures or therapies for common conditions in Clinical Immunology and Allergy CLINICAL IMMUNOLOGY AND ALLERGY (2021) (MINOR REVISIONS – OCTOBER 2023)
- ME 3.2 Obtain and document informed consent, explaining the risk and benefits, and the rationale for, a proposed procedure or therapy
- ME 2.2 Determine the patient’s suitability for the proposed procedure/treatment
Communicator
- COM 3.1 Communicate the diagnosis, prognosis and/or plan of care in a clear, compassionate, respectful and accurate manner
- COM 4.3 Answer questions from the patient and family about next steps
- COM 5.1 Document clinical encounters to adequately convey clinical reasoning and the rationale for decisions
Collaborator
- COL 1.1 Receive and appropriately respond to input from other health care professionals CLINICAL IMMUNOLOGY AND ALLERGY (2021) (MINOR REVISIONS – OCTOBER 2023)
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
F-3AP
Performing interventions for uncomplicated patients
Key features and assessment plan
- This EPA builds on the procedural competencies from TTDiscipline and includes performing and interpreting epicutaneous testing and intradermal testing, interpreting spirometry, initiating and monitoring provocation challenges, and preparing and administering medications (such as epinephrine, immunotherapy, vaccines, dilutions, etc.). - It also includes understanding factors that can influence the accuracy, reliability or safety of procedures in allergy and immunology (e.g., dermatographism, causes of false positive and false negative test results). - This EPA does not include determining WHEN to offer a provocation challenge or desensitization.
Direct and/or indirect observation by faculty, senior trainee, respiratory therapist, registered nurse or experienced technician Use form 2. Form collects information on: - Procedure: epicutaneous testing; intradermal testing; food provocation challenge; drug provocation challenge; allergen immunotherapy (e.g., subcutaneous, sublingual, oral); preparing and administering medications (e.g., dilutions) - Setting: inpatient; outpatient; simulation - Age: infant; toddler; child; adolescent; adult; older adult Collect 6 observations of achievement. - At least 1 of each procedure - A variety of ages - At least 2 different observers
Suggested observations: 6
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Procedure
- epicutaneous testing
- intradermal testing
- food provocation challenge
- drug provocation challenge
- allergen immunotherapy (e.g., subcutaneous, sublingual, oral)
- preparing and administering medications (e.g., dilutions)
Setting
- inpatient
- outpatient
- simulation
Age
- infant
- toddler
- child
- adolescent
- adult
- older adult
Medical Expert
- ME 3.2 Obtain and document informed consent, explaining the risks and benefits of, and the rationale for, a proposed procedure or therapy
- ME 3.4 Perform pre-procedural tasks in a timely, skillful, and safe manner
- ME 3.4 Perform procedures in a skillful and safe manner, adapting to unanticipated findings or changing clinical circumstances
- ME 3.4 Document procedures accurately
- ME 3.4 Establish and implement a plan for post-procedure care CLINICAL IMMUNOLOGY AND ALLERGY (2021) (MINOR REVISIONS – OCTOBER 2023)
- ME 3.4 Recognize and manage complications
- ME 3.4 Assess the quality and validity of the study, and any impact on the diagnostic interpretation
- ME 2.2 Interpret results of investigations/procedures based on clinical situation
Communicator
- COM 5.1 Document the encounter to adequately convey the procedure and outcome CLINICAL IMMUNOLOGY AND ALLERGY (2021) (MINOR REVISIONS – OCTOBER 2023)
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
F-4AP
Identifying personal learning needs while caring for patients, and addressing those needs
Key features and assessment plan
- This EPA focuses on engaging in self-assessment and personal professional development as part of clinical activities - This EPA includes: identifying personal learning needs, knowledge gaps and/or areas for further development; utilizing resources to address these limitations; and, reflecting on the outcome - This EPA may include a variety of scenarios. Examples include: a plan to act on the performance gaps identified in another EPA; a plan to prepare for additional training; a plan to prepare for practice in a specific setting (i.e. community) and/or a setting requiring distinct skills. - The observation of this EPA is based on the resident submitting a personal learning plan to a supervisor - Achievement of this EPA includes providing a) the rationale for a learning plan, b) self-reflection, c) personal needs assessment, d) time management and e) identification of the methods to achieve the personal learning plan such as literature review, clinical training, conference attendance and/or rounds attendance
Review of resident’s personal learning plan by supervisor Use form 1. Collect 2 observations of achievement.
Suggested observations: 2
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Leader
- L 4.2 Examine personal interests and career goals
- L 4.2 Adjust educational experiences to gain competencies necessary for future practice
Scholar
- S 1.2 Interpret data on personal performance to identify opportunities for learning and improvement
- S 1.1 Define learning needs related to personal practice and/or career goals
- S 3.1 Generate focused questions that address practice uncertainty and knowledge gaps
- S 1.1 Create a learning plan that is feasible, includes clear deliverables and a plan for monitoring ongoing achievement
- S 1.1 Identify resources required to implement a personal learning plan CLINICAL IMMUNOLOGY AND ALLERGY (2021) (MINOR REVISIONS – OCTOBER 2023)
Professional
- P 2.1 Demonstrate a commitment to maintaining and enhancing competence CLINICAL IMMUNOLOGY AND ALLERGY (2021) (MINOR REVISIONS – OCTOBER 2023)
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
Core
C-1AP
Establishing a comprehensive diagnostic and treatment plan for patients with complex allergic presentations
Key features and assessment plan
- This EPA focuses on definitive investigation, clinical reassessment, and development of the treatment plan for patients with complex allergic presentations. - Examples include allergic rhinoconjunctivitis/sinusitis, anaphylaxis, asthma, atopic and contact dermatitis, food allergy, venom allergy, urticaria and angioedema, drug hypersensitivity, mast cell disorders, and eosinophilic disorders. - This EPA may be observed in a simulation setting.
Direct observation and/or review of case, consult letter and/or action plan by faculty or senior trainee Use form 2. Form collects information on: - Presentation: allergic rhinoconjunctivitis/sinusitis; anaphylaxis; asthma; atopic and contact dermatitis; drug hypersensitivity; food allergy; mast cell disorders and eosinophilic disorders; urticaria and angioedema; venom allergy; other (write in) - Setting: inpatient; outpatient; simulation - Age: infant; toddler; children; adolescents; adult; older adult Collect 5 observations of achievement. - A variety of clinical presentations - No more than 2 in simulation setting - At least 1 pediatric patient - At least 1 adult patient - At least 2 different assessors - At least 4 faculty observations
Suggested observations: 5
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Presentation
- allergic rhinoconjunctivitis/sinusitis
- anaphylaxis
- asthma
- atopic and contact dermatitis
- drug hypersensitivity
- food allergy
- mast cell disorders and eosinophilic disorders
- urticaria and angioedema
- venom allergy
- other (write in)
Setting
- inpatient
- outpatient
- simulation
Age
- infant
- toddler
- children
- adolescents
- adult
- older adult
Medical Expert
- ME 2.2 Perform complete and appropriate assessment, including consideration of competing treatment needs, in a time-effective manner
- ME 2.2 Select and interpret appropriate investigations based on a differential diagnosis
- ME 2.2 Generate and prioritize the differential diagnoses
- ME 3.1 Develop a procedural or therapeutic plan that is safe, patient- centred, and considers the risks and benefits of all approaches CLINICAL IMMUNOLOGY AND ALLERGY (2021) (MINOR REVISIONS – OCTOBER 2023)
- ME 2.4 Establish a plan to monitor the clinical course and/or the patient’s response to treatment
- ME 4.1 Establish plans for ongoing care
Communicator
- COM 3.1 Provide information to patients and their families clearly and compassionately
- COM 5.1 Document clinical encounters to adequately convey clinical reasoning and the rationale for decisions
Collaborator
- COL 1.2 Work effectively with other health care professionals, including other physicians
Leader
- L 2.1 Demonstrate resource stewardship in clinical care CLINICAL IMMUNOLOGY AND ALLERGY (2021) (MINOR REVISIONS – OCTOBER 2023)
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-2AP
Establishing a comprehensive diagnostic and treatment plan for patients with complex presentations in clin…
Key features and assessment plan
- This EPA focuses on definitive investigation, clinical reassessment, and development of the treatment plan for patients with inborn errors of immunity and secondary immunodeficiencies. - This EPA may be observed in the simulation setting.
Direct observation and/or review of case, consult letter and/or treatment plan by faculty and/or senior trainee Use form 2. Form collects information on: - Presentation: severe combined immunodeficiency; combined immunodeficiency; humoral deficiency; immune dysregulation disorder; phagocytic defect and/or innate immune defect; autoinflammatory disorder; complement deficiency; secondary immunodeficiency; transplant immunology; autoimmunity; immune replacement therapy; other (write in) - Setting: inpatient; outpatient; simulation - Age: infant; toddler; child; adolescent; adult; older adult Collect 5 observations of achievement. - A variety of clinical presentations - No more than 2 in simulation setting - A variety of settings - At least 1 adult patient - At least 1 pediatric patient - At least 4 faculty observations - At least 2 different assessors
Suggested observations: 5
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Presentation
- severe combined immunodeficiency
- combined immunodeficiency
- humoral deficiency
- immune dysregulation disorder
- phagocytic defect and/or innate immune defect
- autoinflammatory disorder
- complement deficiency
- secondary immunodeficiency
- transplant immunology
- autoimmunity
- immune replacement therapy
- other (write in)
Setting
- inpatient
- outpatient
- simulation
Age
- infant
- toddler
- child
- adolescent
- adult
- older adult
Medical Expert
- ME 2.2 Perform a complete and appropriate assessment, including consideration of competing treatment needs, in a time-effective manner
- ME 2.2 Select and interpret appropriate investigations based on a differential diagnosis
- ME 2.2 Generate and prioritize the differential diagnoses
- ME 3.1 Develop a procedural or therapeutic plan that is safe, patient- centred, and considers the risks and benefits of all approaches CLINICAL IMMUNOLOGY AND ALLERGY (2021) (MINOR REVISIONS – OCTOBER 2023)
- ME 2.4 Establish a plan to monitor the clinical course and/or the patient’s response to treatment
- ME 4.1 Establish plans for ongoing care
Communicator
- COM 3.1 Provide information to patients and their families clearly and compassionately
- COM 5.1 Document clinical encounters to adequately convey clinical reasoning and the rationale for decisions
Collaborator
- COL 1.2 Work effectively with other health care professionals, including other physicians
Leader
- L 2.1 Demonstrate resource stewardship in clinical care CLINICAL IMMUNOLOGY AND ALLERGY (2021) (MINOR REVISIONS – OCTOBER 2023)
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-3AP
Advocating for patients with immunologic and allergic conditions
Key features and assessment plan
- This EPA focuses on the role of the specialist in communicating with external organizations (e.g. school, workplace, government, social services) and/or caregivers for the health and safety of patients. - This EPA also includes identifying a need for advocacy, identifying resources, and establishing a plan. - It may also include other types of advocacy; examples are: completing documentation (such as asthma/anaphylaxis action plans, disability applications), arranging for language interpretation, and writing letters on behalf of the patient.
Direct and/or indirect observation by faculty and/or other health professional with input from members of the interprofessional team Use form 1. Form collects information on: - Context: simulation; clinical encounters; communication with outside organizations; letter for patients and/or organizations; forms; presentation; lecture; promotional/prevention/educational material for patients, caregivers or communities Collect 4 observations of achievement. - At least 2 different contexts
Suggested observations: 4
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Context
- simulation
- clinical encounters
- communication with outside organizations
- letter for patients and/or organizations
- forms
- presentation
- lecture
- promotional/prevention/educational material for patients, caregivers or communities
Medical Expert
- ME 2.2 Assess an individual’s need for services, resources and/or accommodations in the workplace/school
Communicator
- COM 3.1 Convey information related to the patient’s health status, care, and needs in a timely, honest, and transparent manner CLINICAL IMMUNOLOGY AND ALLERGY (2021) (MINOR REVISIONS – OCTOBER 2023)
- COM 5.3 Share information in a manner that respects patient privacy and confidentiality and enhances understanding
- COM 5.1 Complete third party clinical documentation in a thorough, responsible and timely manner CLINICAL IMMUNOLOGY AND ALLERGY (2021) (MINOR REVISIONS – OCTOBER 2023)
Leader
- L 3.1 Apply knowledge of the resources available in various health care and community settings
Health Advocate
- HA 1.1 Facilitate timely patient access to health services and resources
- HA 1.2 Work with the patient and family to increase opportunities to adopt healthy behaviours
- HA 1.3 Incorporate disease prevention, health promotion, and health surveillance activities into interactions with individual patients
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-4AP
Managing medical emergencies
Key features and assessment plan
- This EPA focuses on the assessment and management of allergy and immunology medical emergencies in hospital or community clinic settings, with remote support of an attending physician. - Patient presentations may include: allergic reactions including anaphylaxis, unstable asthma, angioedema, transfusion/infusion reactions, and other medical emergencies (such as severe combined immunodeficiency (SCID). - The observation of this EPA is divided into two parts: patient care and interprofessional collaboration. - This EPA may be observed in the simulation setting.
Part A: Patient care Direct observation and/or case review by faculty or senior trainee Use form 2. Form collects information on: - Observation type: direct; case review - Category: allergic; immunologic - Presentation (write in): - Age: infant; toddler; child; adolescent; adult; older adult - Setting: inpatient; outpatient; medical day unit; ER; ICU; simulation - Complexity: low; moderate; high Collect 3 observations of achievement. - At least 2 by direct observation - A variety of clinical presentations - A variety of complexities - No more than 2 in simulation setting - At least 2 different observers - At least 2 observations by faculty Part B: Working effectively with the interprofessional team Direct observation by faculty, senior trainee, or nurse, which may include input from other members of the team (e.g. respiratory therapist, certified asthma educator, technologist) Use form 1. Form collects information on: - Includes feedback from: nurse; nurse practitioner; respiratory therapist; physician; other learners; other health professional Collect 2 observations of achievement. - At least 2 people providing feedback for each observation, of which at least one is not a physician CLINICAL IMMUNOLOGY AND ALLERGY (2021) (MINOR REVISIONS – OCTOBER 2023)
Suggested observations: 3
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Observation type
- direct
- case review
Category
- allergic
- immunologic
Medical Expert
- Part A: ME 2.1 Assess the priorities of resuscitation – airway, breathing circulation (ABC’s)
- Part A: ME 2.4 Develop and implement a management plan
- Part A: ME 2.4 Provide concurrent treatment and ongoing assessment of the patient’s clinical condition
- Part A: ME 2.4 Reassess, re-evaluate and adjust resuscitative and diagnostic efforts as appropriate
- Part A: ME 4.1 Determine the need and timing of referral to another health care professional or setting
- Part A: ME 1.4 Act decisively and maintain control of crisis situations
Communicator
- Part A: COM 5.1 Document the encounter to convey the outcome and rationale for clinical decisions
Collaborator
- Part A: COL 1.1 Receive and appropriately respond to input from other members of the team
- Part B: COL 2.1 Delegate tasks and responsibilities in an appropriate and respectful manner
- Part B: COL 1.2 Seek and respond to input from members of the health care team
- Part B: COL 1.2 Communicate effectively with the health care team using clear language and keeping them informed of management plans and rationale
- Part B: COL 2.2 Identify communication barriers and promote positive communication between health care professionals CLINICAL IMMUNOLOGY AND ALLERGY (2021) (MINOR REVISIONS – OCTOBER 2023)
Leader
- Part B: L 4.2 Establish clear leadership in resuscitative efforts
Professional
- Part A: P 4.1 Maintain capacity for professional clinical performance in stressful situations
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-5AP
Performing provocation challenges and desensitization
Key features and assessment plan
- This EPA focuses on food challenges, drug/vaccine challenges, and desensitizations. - This EPA includes all of the following: consent; preparation; performance; post- procedural care including documentation; and managing any immediate complications. - This EPA may be observed in the simulation setting.
Direct observation and/or case review by faculty, senior trainee, or nurse, with feedback from patient and/or family if applicable Use form 2. Form collects information on: - Case mix: food challenge; drug/vaccine challenge; desensitization - Setting: inpatient; outpatient; simulation - Complexity: simple; complex - Age: infant; toddler; child; adolescent; adult; older adult Collect 3 observations of achievement. - At least 1 food challenge - At least 1 drug/vaccine challenge - At least 1 desensitization - No more than 1 in simulation setting - A variety of ages
Suggested observations: 3
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Case mix
- food challenge
- drug/vaccine challenge
- desensitization
Setting
- inpatient
- outpatient
- simulation
Complexity
- simple
- complex
Age
- infant
- toddler
- child
- adolescent
- adult
- older adult
Medical Expert
- ME 2.2 Perform a focused clinical assessment without excluding key elements
- ME 2.2 Assess a patient’s suitability to proceed with a challenge or desensitization
- ME 3.1 Select the test protocol relevant to the clinical question and patient condition
- ME 3.2 Obtain and document informed consent, explaining the risks and benefits of, and rationale for a proposed procedure or therapy
- ME 3.4 Perform or supervise the procedure
- ME 3.4 Monitor patient comfort and safety, and adjust the procedure as needed CLINICAL IMMUNOLOGY AND ALLERGY (2021) (MINOR REVISIONS – OCTOBER 2023)
- ME 3.4 Manage immediate complications of the procedure, as relevant
- ME 3.4 Seek assistance as needed when unanticipated findings or changing clinical circumstances are encountered
- ME 3.4 Establish and implement a plan for post-procedure care
Communicator
- COM 3.1 Address patient/family concerns, questions and anxiety throughout the procedure
- COM 5.1 Document the encounter to adequately convey the procedure and outcome CLINICAL IMMUNOLOGY AND ALLERGY (2021) (MINOR REVISIONS – OCTOBER 2023)
Collaborator
- COL 1.2 Communicate effectively with nurses during the procedure
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-6AP
Performing and interpreting pulmonary function tests
Key features and assessment plan
- This EPA includes bronchial provocation challenge, spirometry and peak flow measurement. - The observation of this EPA is divided into two parts: direct observation of the procedures; and interpretation of pulmonary function tests.
Part A: Direct observation of procedure Direct observation by faculty, senior trainee, respiratory therapist, or other health professional trained to do spirometry Use form 2. Form collects information on: - Case mix: spirometry; peak flow - Setting: inpatient; outpatient - Patient age: child; adolescent; adult; older adult - Complexity: simple; complex Collect 2 observations of achievement - At least 1 spirometry - At least 1 peak flow - At least 2 observers Part B: Interpretation Review of diagnostic test interpretation by faculty or senior trainee Use form 2. Form collects information on: - Case mix: bronchial provocation challenge; spirometry; peak flow meter; complete PFT - Setting: inpatient; outpatient; simulation - Patient age: child; adolescent; adult; older adult - Presentation (write in): - Complexity: simple; complex Collect 4 observations of achievement. - At least 2 complete PFTs - A variety of ages - A variety of presentations - A variety of complexity - At least 2 observers - At least 1 faculty CLINICAL IMMUNOLOGY AND ALLERGY (2021) (MINOR REVISIONS – OCTOBER 2023)
Suggested observations: 2
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Case mix
- spirometry
- peak flow
Setting
- inpatient
- outpatient
Patient age
- child
- adolescent
- adult
- older adult
Complexity
- simple
- complex
Medical Expert
- Part A: ME 2.2 Perform a focused clinical assessment without excluding key elements
- Part A: ME 2.2 Assess a patient’s suitability to proceed with spirometry/peak flow assessment
- Part A: ME 3.2 Obtain and document informed consent, explaining the risks and benefits of, and the rationale for, a proposed procedure or therapy
- Part A: ME 3.4 Assemble/gather the equipment
- Part A: ME 3.4 Prepare and position the patient for the procedure
- Part A: ME 3.4 Coach the patient through the steps of the procedure
- Part A: ME 3.4 Monitor patient comfort and safety, and adjust the procedure as needed
- Part A: ME 3.4 Modify or adjust the procedure as needed to optimize study quality
- Part A: ME 3.4 Manage immediate complications of the procedure, as relevant
- Part B: ME 1.3 Apply knowledge of respiratory physiology
- Part B: ME 1.3 Apply knowledge of the technical components of diagnostic testing including equipment and protocols
- Part B: ME 3.4 Assess the quality and validity of the study, and any impact on the diagnostic interpretation
- Part B: ME 3.4 Interpret respiratory diagnostic investigations
- Part B: ME 3.4 Summarize findings of clinical relevance, and provide suggestions for further testing and/or management as appropriate
Communicator
- Part A: COM 3.1 Provide explanations that are clear and accurate while checking for understanding
- Part B: COM 5.1 Provide clear, concise and accurate reports of diagnostic testing in a timely fashion CLINICAL IMMUNOLOGY AND ALLERGY (2021) (MINOR REVISIONS – OCTOBER 2023)
- Part B: COM 5.1 Communicate critical results urgently, as needed CLINICAL IMMUNOLOGY AND ALLERGY (2021) (MINOR REVISIONS – OCTOBER 2023)
Scholar
- Part B: S 3.4 Integrate best evidence and clinical expertise
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-7AP
Providing care for patients who have experienced a patient safety incident (adverse event)
Key features and assessment plan
- This EPA focuses on the response to an individual patient who has experienced a patient safety incident. A patient safety incident is defined as an event or circumstance which could have resulted, or did result, in unnecessary harm to the patient. There are 3 types: harmful incident, no harm incident, and near miss. - This EPA includes providing specific medical care, disclosure of the event to the patient/family, as well as documentation and reporting of the incident and reflection on practice. - This EPA may be observed in the simulation setting.
Direct observation or case review by faculty or other health professional Use form 2. Form collects information on: - Safety incident type: harmful incident; no harm incident; near miss - Presentation (write in): - Age: infant; toddler; child; adolescent; adult; older adult - Setting: inpatient; outpatient; simulation; medical day unit; ICU - Observation type: direct; case review Collect 2 observations of achievement. - At least 2 different observers - At least 1 observation by faculty - At least 1 direct observation
Suggested observations: 2
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Safety incident type
- harmful incident
- no harm incident
- near miss
Medical Expert
- ME 5.1 Identify a patient safety incident in a timely manner
- ME 5.1 Identify the clinical circumstances contributing to an adverse event
- ME 5.1 Intervene to mitigate further injury
- ME 2.4 Develop and implement initial management plans
- ME 5.1 Document harmful patient safety incidents as per institutional processes
- ME 5.1 Identify changes in practice/clinical care to prevent similar events
Communicator
- COM 3.2 Communicate the reasons for unanticipated clinical outcomes to the patients and disclose patient safety incidents
- COM 3.2 Apologize appropriately for a harmful patient safety incident
- COM 4.3 Answer questions from the patient and family about next steps CLINICAL IMMUNOLOGY AND ALLERGY (2021) (MINOR REVISIONS – OCTOBER 2023)
Professional
- P 4.1 Apply strategies to mitigate the personal impact of patient safety incidents CLINICAL IMMUNOLOGY AND ALLERGY (2021) (MINOR REVISIONS – OCTOBER 2023)
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-8AP
Identifying and referring patients who need additional specialized care
Key features and assessment plan
- This EPA focuses on the identification of patients who require, or who would benefit from assessment and/or treatment that is beyond the scope of Clinical Immunology/Allergy practice. - This EPA includes completion of appropriate investigations and identification of the appropriate timing and urgency of referral, as well as communication and collaboration with the consultant. - This EPA may be observed in any clinical setting and in a range of conditions.
Direct observation and/or review of case and/or documentation by supervisor, consultant or other collaborator Use form 2. Form collects information on: - Observer role: supervisor; consultant; other - Setting: inpatient; outpatient - Presentation (write in): Collect 3 observations of achievement. - A variety of presentations - At least 2 different observers
Suggested observations: 3
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Observer role
- supervisor
- consultant
- other
Setting
- inpatient
- outpatient
Medical Expert
- ME 2.2 Synthesize information from the clinical assessment and investigations to determine the patient’s clinical status and health care needs
- ME 4.1 Determine the need and timing of referral to another health care professional or setting
Collaborator
- COL 1.3 Consult as needed with other health care professionals, including other physicians
- COL 1.3 Communicate effectively with physicians and other health care professionals
- COL 1.3 Provide timely and necessary written information to colleagues to enable effective relationship-centred care CLINICAL IMMUNOLOGY AND ALLERGY (2021) (MINOR REVISIONS – OCTOBER 2023)
- COL 1.3 Engage in respectful shared decision-making with physicians and other colleagues in the health care professions CLINICAL IMMUNOLOGY AND ALLERGY (2021) (MINOR REVISIONS – OCTOBER 2023)
Leader
- L 2.1 Apply knowledge of local resources for optimal patient care
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-9AP
Teaching
Key features and assessment plan
- This EPA focuses on teaching other learners, including medical students, residents, faculty, and/or other health professionals, in formal and informal (clinical) settings. - Examples include: bedside teaching, presentations, one-on-one teaching, case based teaching, tutorials, and/or procedures. - The observation of this EPA is divided into two parts: formal teaching, and informal teaching. - Formal teaching focuses on the skills of critical appraisal, as well as presentation and teaching skills. - Informal teaching includes collaboratively identifying the learning needs of others, establishing a safe learning environment, sharing knowledge and expertise and demonstrating effective teaching skills.
Part A: Formal teaching Direct observation by supervisor, preferably incorporating feedback from audience Use Form 1. Form collects information on - Type of activity: journal club; grand rounds; case presentation; other Collect 2 observations of achievement. Part B: Informal teaching Direct and/or indirect observation by supervisor, incorporating feedback from the residents and/or students Use Form 1. Form collects information on: - Setting (write in): Collect 2 observations of achievement.
Suggested observations: 2
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Type of activity
- journal club
- grand rounds
- case presentation
- other
Collaborator
- Part B: COL 2.1 Delegate tasks and responsibilities in an appropriate and respectful manner
Scholar
- Part A: S 2.4 Identify the learning needs and desired learning outcomes of others
- Part A: S 2.4 Develop learning objectives for a teaching activity
- Part A: S 3.3 Critically evaluate the integrity, reliability and applicability of health related research and literature CLINICAL IMMUNOLOGY AND ALLERGY (2021) (MINOR REVISIONS – OCTOBER 2023)
- Part A: S 3.4 Integrate best evidence and clinical expertise
- Part A: S 2.4 Present the information in an organized manner to facilitate understanding
- Part A: S 2.4 Use audiovisual aids effectively
- Part A: S 2.4 Provide adequate time for questions and discussion
- Part B: S 2.2 Create a positive learning environment
- Part B: S 2.3 Be available and accessible to junior learners
- Part B: S 2.4 Identify the learning needs and desired learning outcomes of others
- Part B: S 2.4 Provide clinical teaching and/or other informal learning activities
- Part B: S 2.5 Provide feedback to enhance learning and performance
- Part B: S 3.4 Integrate best evidence and clinical expertise into decision-making
Professional
- Part B: P 1.1 Intervene when behaviours toward colleagues and/or learners undermine a respectful environment CLINICAL IMMUNOLOGY AND ALLERGY (2021) (MINOR REVISIONS – OCTOBER 2023)
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-10AP
Advancing the discipline through scholarly activities
Key features and assessment plan
- This EPA includes all aspects of performing scholarly work: identification of a question for investigation, literature review, data gathering, data analysis, reflective critique and dissemination. - This may include scholarly research, quality assurance, or educational projects. - The assessment of this EPA is based on the completion of a scholarly project, or presentation of scholarly work to date.
Direct and/or indirect observation by supervisor Use Form 1 Collect 1 observation of achievement
Suggested observations: 1
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Scholar
- S 4.4 Identify, consult, and collaborate with content experts and others in the conduct of scholarly work
- S 4.4 Generate focused questions for scholarly investigation
- S 3.3 Critically evaluate the integrity, reliability, and applicability of health literature
- S 4.4 Select appropriate methods of addressing a given scholarly question
- S 4.2 Identify ethical principles in research
- S 4.3 Actively participate as a research team member, balancing the roles and responsibilities of a researcher with the clinical roles and responsibilities of a physician
- S 4.4 Collect data and determine appropriate analysis
- S 4.4 Integrate existing literature and findings of data collection
- S 4.5 Summarize and communicate the findings of research and scholarly inquiry and identify areas for further investigation CLINICAL IMMUNOLOGY AND ALLERGY (2021) (MINOR REVISIONS – OCTOBER 2023)
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
Transition to Practice
TTP-1AP
Assessing and managing patients in whom there is uncertainty/complexity in diagnosis, treatment and/or p…
Key features and assessment plan
- This EPA focuses on the clinical reasoning involved in the treatment of patients for whom there is uncertainty/complexity in the diagnosis despite appropriate clinical assessment, and/or uncertainty in determining optimal therapy and/or prognosis. - This EPA includes clinical assessment and management, as well as effective communication of uncertainty to the patient and/or family and primary care or referring physician.
Direct observation and/or case review by faculty Use form 2. Form collects information on: - Observation type: direct; case review - Category: allergic; immunologic - Age: infant; toddler; child; adolescent; adult; older adult - Setting: inpatient; outpatient - Presentation [write in]: Collect 4 observations of achievement. - At least 2 by direct observation - A variety of clinical presentations - At least 2 different observers
Suggested observations: 4
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Observation type
- direct
- case review
Category
- allergic
- immunologic
Age
- infant
- toddler
- child
- adolescent
- adult
- older adult
Setting
- inpatient
- outpatient
Medical Expert
- ME 1.6 Recognize and respond to the complexity, uncertainty, and ambiguity inherent in Clinical Immunology and Allergy practice
- ME 2.4 Demonstrate flexibility in clinical reasoning, in the setting of clinical uncertainty
- ME 2.1 Prioritize which issues need to be addressed
- ME 2.2 Synthesize patient information
- ME 2.2 Revise the differential diagnosis in response to new clinical information, or response to treatment
- ME 2.4 Establish a patient centered management plan despite limited, non- diagnostic, or conflicting clinical data CLINICAL IMMUNOLOGY AND ALLERGY (2021) (MINOR REVISIONS – OCTOBER 2023)
Communicator
- COM 3.1 Convey information related to the uncertainty in diagnosis and/or treatment in a clear, timely and transparent manner
- COM 4.1 Use communication skills and strategies that help the patient make informed decisions
- COM 5.1 Document clinical encounters to adequately convey clinical reasoning and the rationale for decisions
Collaborator
- COL 1.3 Consult as needed with other health care professionals, including other physicians
Scholar
- S 3.1 Generate focused clinical questions relevant to patient diagnoses or management to guide literature searches
- S 3.4 Critically appraise relevant medical literature to make evidence informed medical decisions
Professional
- P 1.1 Identify limits in their own expertise CLINICAL IMMUNOLOGY AND ALLERGY (2021) (MINOR REVISIONS – OCTOBER 2023)
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
TTP-2AP
Managing the multidimensional aspects of a clinical immunology and allergy practice
Key features and assessment plan
- This EPA focuses on managing the caseload of an allergist-immunologist, which includes: triaging referrals and managing calls; providing quality care for individual patients; triaging and prioritizing among cases and other demands; and, managing time/tasks appropriately - This EPA may include identifying the mental and physical challenges that may impact physician wellness and/or performance in demanding or stressful clinical settings. - This EPA may be observed in any clinical setting. Ideally, it would be observed in a community practice setting. - The observation of this EPA is not based on a single patient encounter, but rather on the resident performance over at least one week.
Direct and/or indirect observation by supervisor with input from other health professionals and/or patients Use form 2. Form collects information on: - Length of observation (weeks) (write in): Collect 2 observations of achievement. - At least 2 different faculty observers, ideally a community based affiliated faculty as one observer if available
Suggested observations: 2
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Medical Expert
- ME 1.1 Demonstrate responsibility and accountability for decisions regarding patient care, acting in the role of most responsible physician
- ME 1.4 Perform relevant and time-effective clinical assessments
- ME 1.5 Prioritize patients based on the urgency of clinical presentations
- ME 1.5 Carry out professional duties in the face of multiple, competing demands
- ME 2.4 Establish patient centered management plans CLINICAL IMMUNOLOGY AND ALLERGY (2021) (MINOR REVISIONS – OCTOBER 2023)
Leader
- L 2.1 Allocate health care resources for optimal patient care
- L 4.1 Set priorities and manage time to fulfil diverse responsibilities
Scholar
- S 3.4 Integrate best evidence and clinical expertise into decision-making
Professional
- P 4.1 Manage the mental and physical challenges that impact physician wellness and/or performance in demanding or stressful clinical settings
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.